SV BR 1 GM cancer vaccine (BriaCell Therapeutics)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameSV BR 1 GM cancer vaccine (BriaCell Therapeutics)
Drug Alias NameAllogeneic GM CSF secreting breast cancer vaccine (BriaCell Therapeutics)SV BR 1转基因肿瘤疫苗GM CSF gene-transfected breast cancer vaccine (BriaCell Therapeutics)BriaVaxBria-IMT +[6] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulantsImmunostimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsBrain metastasesMetastatic breast cancerMeningeal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesWiseman Research Initiatives Llc
China Registration ClassN/A

Develop Information

Active CompaniesBriacell Therapeutics CorpThe Medical College Of Wisconsin Nonprofit
Inactive CompaniesThomas Jefferson University
Active IndicationsBrain metastasesMetastatic breast cancerMeningeal Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A